vimarsana.com

Latest Breaking News On - Travere therapeutics company profile - Page 1 : vimarsana.com

Brokerages Set Travere Therapeutics, Inc (NASDAQ:TVTX) Target Price at $16 69

Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) has been given a consensus rating of “Moderate Buy” by the thirteen research firms that are presently covering the stock, Marketbeat.com reports. Five analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 12-month price objective […]

Analysts Set Travere Therapeutics, Inc (NASDAQ:TVTX) Target Price at $17 85

Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) has received an average rating of “Moderate Buy” from the fifteen analysts that are covering the firm, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 1-year price objective […]

Brokerages Set Travere Therapeutics, Inc (NASDAQ:TVTX) Target Price at $17 85

Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the fifteen analysts that are presently covering the company, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.